- Home
- PRU vs TAK Comparison
PRU vs TAK Comparison
Compare PRU & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRU
- TAK
- Stock Information
- Founded
- PRU 1875
- TAK 1781
- Country
- PRU United States
- TAK Japan
- Employees
- PRU N/A
- TAK N/A
- Industry
- PRU Life Insurance
- TAK Biotechnology: Pharmaceutical Preparations
- Sector
- PRU Finance
- TAK Health Care
- Exchange
- PRU Nasdaq
- TAK Nasdaq
- Market Cap
- PRU 37.2B
- TAK 47.3B
- IPO Year
- PRU N/A
- TAK N/A
- Fundamental
- Price
- PRU $103.00
- TAK $15.10
- Analyst Decision
- PRU Hold
- TAK
- Analyst Count
- PRU 13
- TAK 0
- Target Price
- PRU $122.08
- TAK N/A
- AVG Volume (30 Days)
- PRU 1.5M
- TAK 3.1M
- Earning Date
- PRU 10-29-2025
- TAK 10-30-2025
- Dividend Yield
- PRU 5.25%
- TAK 3.60%
- EPS Growth
- PRU N/A
- TAK N/A
- EPS
- PRU 4.51
- TAK 0.59
- Revenue
- PRU $59,209,000,000.00
- TAK $31,053,301,865.00
- Revenue This Year
- PRU N/A
- TAK $0.18
- Revenue Next Year
- PRU $5.19
- TAK $0.56
- P/E Ratio
- PRU $22.79
- TAK $25.55
- Revenue Growth
- PRU N/A
- TAK 1.52
- 52 Week Low
- PRU $90.38
- TAK $12.80
- 52 Week High
- PRU $130.55
- TAK $15.69
- Technical
- Relative Strength Index (RSI)
- PRU 39.97
- TAK 51.36
- Support Level
- PRU $101.64
- TAK $14.87
- Resistance Level
- PRU $107.44
- TAK $15.38
- Average True Range (ATR)
- PRU 2.03
- TAK 0.18
- MACD
- PRU -0.64
- TAK -0.03
- Stochastic Oscillator
- PRU 16.06
- TAK 27.44
About PRU Prudential Financial Inc.
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2024 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 40% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 10% of its 2024 adjusted earnings and has around $1.4 trillion in assets under management.
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.